| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $466.4M | — | +9.1% |
| Cost of Revenue | $336.8M | — | +9.3% |
| Gross Profit | $129.6M | — | +8.6% |
| R&D Expense | $39.6M | — | +10.1% |
| SG&A Expense | $25.0M | — | +5.6% |
| Operating Income | $69.4M | — | +1208.0% |
| Pre-tax Income | $69.1M | — | +742.4% |
| Income Tax | $10.1M | — | +600.6% |
| Net Income | $59.1M | — | +775.0% |
| EPS (Basic) | $0.21 | — | +800.0% |
| EPS (Diluted) | $0.20 | — | +766.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $150.3M | +24.3% | -30.5% |
| Accounts Receivable | $309.9M | -14.0% | +1.6% |
| Current Assets | $521.1M | -6.6% | -9.8% |
| Total Assets | $1.56B | -3.4% | -5.8% |
| Current Liabilities | $460.9M | -11.5% | +5.4% |
| Long-term Debt | $66.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $108.7M | — | +125.8% |
| Capital Expenditures | $18.4M | — | +52.6% |
| Investing Cash Flow | -$18.4M | — | -122.4% |
| Financing Cash Flow | -$60.7M | — | -18.4% |
| Free Cash Flow | $90.3M | — | +150.3% |
| -47.5% |
| Stockholders' Equity | $955.3M | +5.3% | -5.2% |